Gambaran Umum
MicroPort CardioFlow Medtech Corporation, based in China, operates primarily in the medical devices industry, focusing on the development, production, and commercialization of innovative cardiovascular devices. A key subsidiary of the global medical device conglomerate MicroPort Scientific Corporation, CardioFlow Medtech has carved a niche in the minimally invasive heart valve therapeutic area. The company has been instrumental in advancing transcatheter aortic valve implantation (TAVI) technologies, prominently through its flagship project, the VitaFlow® Transcatheter Aortic Valve and Delivery System, which addresses severe aortic stenosis. Leveraging cutting-edge research and clinical trials, CardioFlow Medtech aims to enhance patient outcomes while expanding its market presence both domestically and internationally.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk MicroPort CardioFlow Medtech Corporation per 2025 Jun 30 adalah 367.53 MM.
- Nilai operating income untuk MicroPort CardioFlow Medtech Corporation per 2025 Jun 30 adalah -97.88 MM.
- Nilai net income untuk MicroPort CardioFlow Medtech Corporation per 2025 Jun 30 adalah 4.85 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 367.53 | -97.88 | 4.85 |
| 2025-03-31 | 364.55 | -117.87 | -22.30 |
| 2024-12-31 | 361.56 | -137.87 | -49.45 |
| 2024-09-30 | 372.24 | -213.70 | -199.02 |
| 2024-06-30 | 382.91 | -289.54 | -348.59 |
| 2024-03-31 | 359.56 | -345.69 | -410.06 |
| 2023-12-31 | 336.21 | -401.84 | -471.53 |
| 2023-09-30 | 319.45 | -416.38 | -491.48 |
| 2023-06-30 | 302.69 | -430.91 | -511.42 |
| 2023-03-31 | 276.86 | -398.37 | -482.91 |
| 2022-12-31 | 251.03 | -365.84 | -454.39 |
| 2022-09-30 | 245.21 | -299.40 | -344.99 |
| 2022-06-30 | 239.40 | -232.97 | -235.58 |
| 2022-03-31 | 220.11 | -206.39 | -209.42 |
| 2021-12-31 | 200.81 | -179.81 | -183.26 |
| 2021-09-30 | 176.04 | -219.94 | -264.81 |
| 2021-06-30 | 151.27 | -260.06 | -346.36 |
| 2021-03-31 | 127.60 | -255.09 | -372.22 |
| 2020-12-31 | 103.93 | -250.12 | -398.09 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | -0.02 | |
| 2024-09-30 | -0.08 | -0.08 |
| 2024-06-30 | -0.15 | -0.15 |
| 2024-03-31 | -0.17 | -0.17 |
| 2023-12-31 | -0.20 | |
| 2023-09-30 | -0.21 | -0.21 |
| 2023-06-30 | -0.22 | -0.22 |
| 2023-03-31 | -0.20 | -0.20 |
| 2022-12-31 | -0.19 | |
| 2022-09-30 | -0.15 | -0.15 |
| 2022-06-30 | -0.10 | -0.10 |
| 2022-03-31 | -0.09 | -0.09 |
| 2021-12-31 | -0.08 | |
| 2021-09-30 | -0.12 | -0.12 |
| 2021-06-30 | -0.18 | -0.18 |
| 2021-03-31 | -0.20 | -0.20 |
| 2020-12-31 | -0.23 |
Arus Kas: Operasi, Investasi, Pendanaan
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | -111.67 | -798.50 | -56.31 |
| 2024-09-30 | -139.15 | -408.22 | -61.66 |
| 2024-06-30 | -166.63 | -17.93 | -67.02 |
| 2024-03-31 | -186.81 | -306.99 | -46.31 |
| 2023-12-31 | -206.99 | -596.06 | -25.61 |
| 2023-09-30 | -216.24 | -662.52 | -25.84 |
| 2023-06-30 | -225.50 | -728.99 | -26.07 |
| 2023-03-31 | -204.02 | -454.38 | -81.24 |
| 2022-12-31 | -182.53 | -179.78 | -136.42 |
| 2022-09-30 | -190.97 | -354.28 | -157.68 |
| 2022-06-30 | -199.41 | -528.77 | -178.94 |
| 2022-03-31 | -180.46 | -483.12 | 1,023.74 |
| 2021-12-31 | -161.50 | -437.48 | 2,226.43 |
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 | -109.75 | -56.42 | 676.42 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 |
Efektivitas Manajemen
- roa untuk MicroPort CardioFlow Medtech Corporation pada 2025 Jun 30 adalah -0.02.
- roe untuk MicroPort CardioFlow Medtech Corporation pada 2025 Jun 30 adalah 0.00.
- roic untuk MicroPort CardioFlow Medtech Corporation pada 2025 Jun 30 adalah -0.02.
- croic untuk MicroPort CardioFlow Medtech Corporation pada 2025 Jun 30 adalah -0.41.
- ocroic untuk MicroPort CardioFlow Medtech Corporation pada 2025 Jun 30 adalah -0.05.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | -0.02 | 0.00 | -0.02 | -0.41 | -0.05 |
| 2025-03-31 | -0.02 | -0.01 | -0.02 | 0.00 | 0.00 |
| 2024-12-31 | -0.14 | -0.02 | -0.15 | -0.11 | -0.07 |
| 2024-09-30 | -0.14 | -0.09 | -0.15 | -0.11 | -0.07 |
| 2024-06-30 | -0.16 | -0.15 | -0.20 | -0.33 | -0.09 |
| 2024-03-31 | -0.20 | -0.33 | -0.09 | ||
| 2023-12-31 | -0.17 | -0.18 | -0.18 | -0.31 | -0.08 |
| 2023-09-30 | -0.16 | -0.17 | -0.19 | -0.32 | -0.08 |
| 2023-06-30 | -0.14 | -0.17 | -0.19 | -0.32 | -0.08 |
| 2023-03-31 | -0.14 | -0.16 | -0.18 | 0.00 | -0.07 |
| 2022-12-31 | -0.07 | -0.11 | -0.12 | -0.21 | -0.07 |
| 2022-09-30 | -0.07 | -0.11 | -0.12 | -0.21 | -0.07 |
| 2022-06-30 | -0.05 | -0.07 | -0.08 | -0.27 | -0.06 |
| 2022-03-31 | -0.05 | -0.06 | -0.07 | 0.12 | -0.06 |
| 2021-12-31 | -0.31 | -0.06 | 0.50 | 0.00 | |
| 2021-09-30 | -0.24 | -0.08 | 0.00 | 0.00 | |
| 2021-06-30 | -0.63 | -2.63 | -0.11 | 0.15 | -0.03 |
| 2021-03-31 | -0.68 | -2.82 | -0.11 | 0.15 | -0.03 |
| 2020-12-31 | -0.73 | -3.02 |
Gross Margins
- marjin kotor untuk MicroPort CardioFlow Medtech Corporation pada 2025 Jun 30 adalah 0.69.
- marjin bersih untuk MicroPort CardioFlow Medtech Corporation pada 2025 Jun 30 adalah -0.14.
- marjin operasi untuk MicroPort CardioFlow Medtech Corporation pada 2025 Jun 30 adalah -0.38.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | 0.69 | -0.14 | -0.38 |
| 2025-03-31 | 0.69 | -0.14 | -0.38 |
| 2024-12-31 | 0.71 | -0.91 | -0.76 |
| 2024-09-30 | 0.71 | -0.91 | -0.76 |
| 2024-06-30 | 0.68 | -1.40 | -1.20 |
| 2024-03-31 | 0.68 | -1.40 | -1.20 |
| 2023-12-31 | 0.66 | -1.69 | -1.42 |
| 2023-09-30 | 0.66 | -1.69 | -1.42 |
| 2023-06-30 | 0.65 | -1.69 | -1.42 |
| 2023-03-31 | 0.65 | -1.74 | -1.44 |
| 2022-12-31 | 0.63 | -1.41 | -1.22 |
| 2022-09-30 | 0.63 | -1.41 | -1.22 |
| 2022-06-30 | 0.59 | -0.98 | -0.97 |
| 2022-03-31 | 0.59 | -0.95 | -0.94 |
| 2021-12-31 | 0.50 | -0.91 | -0.90 |
| 2021-09-30 | 0.50 | -1.50 | -1.25 |
| 2021-06-30 | 0.50 | -2.29 | -1.72 |
| 2021-03-31 | 0.47 | -2.92 | -2.00 |
| 2020-12-31 | 0.44 | -3.83 | -1.89 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
